554 related articles for article (PubMed ID: 17132578)
1. Civil society-a leader in HIV prevention and tobacco control.
Malinowska-Sempruch K; Bonnell R; Hoover J
Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
[TBL] [Abstract][Full Text] [Related]
2. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
Ritter A; Cameron J
Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
[TBL] [Abstract][Full Text] [Related]
3. Community-based interventions and alcohol, tobacco and other drugs: foci, outcomes and implications.
Giesbrecht N; Haydon E
Drug Alcohol Rev; 2006 Nov; 25(6):633-46. PubMed ID: 17132579
[TBL] [Abstract][Full Text] [Related]
4. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments.
Spicer N; Harmer A; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
Soc Sci Med; 2011 Dec; 73(12):1748-55. PubMed ID: 22036298
[TBL] [Abstract][Full Text] [Related]
5. Promoting health and preventing disease: an international perspective on youth health promotion.
Nutbeam D
J Adolesc Health; 1997 May; 20(5):396-402. PubMed ID: 9168387
[TBL] [Abstract][Full Text] [Related]
6. Addressing the insidious health and financial burden of tobacco use in Missouri: the role of medical and public health professionals.
Everett KD; Bullock L; Longo DR
Mo Med; 2006; 103(2):175-9. PubMed ID: 16703720
[TBL] [Abstract][Full Text] [Related]
7. Tobacco and cancer: an American Association for Cancer Research policy statement.
Viswanath K; Herbst RS; Land SR; Leischow SJ; Shields PG;
Cancer Res; 2010 May; 70(9):3419-30. PubMed ID: 20388799
[TBL] [Abstract][Full Text] [Related]
8. Political economy of tobacco control policy on public health in Japan.
Desapriya EB; Iwase N; Shimizu S
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):15-33. PubMed ID: 12687722
[TBL] [Abstract][Full Text] [Related]
9. Action plan for a tobacco-free Europe: implementation in central and eastern Europe, 1993-94. WHO Regional Office for Europe.
Eur J Cancer Prev; 1993 Mar; 2(2):117-23. PubMed ID: 8461862
[TBL] [Abstract][Full Text] [Related]
10. Understanding post 9/11 drug control policy and politics in Central Asia.
Latypov A
Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
[TBL] [Abstract][Full Text] [Related]
11. Reducing tobacco harm: research challenges and issues.
Hatsukami DK; Slade J; Benowitz NL; Giovino GA; Gritz ER; Leischow S; Warner KE
Nicotine Tob Res; 2002; 4 Suppl 2():S89-101. PubMed ID: 12573171
[TBL] [Abstract][Full Text] [Related]
12. Control of human parasitic diseases: Context and overview.
Molyneux DH
Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: tobacco control--reducing cancer incidence and saving lives. 2003.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jul; 21(14):2777-86. PubMed ID: 12777442
[TBL] [Abstract][Full Text] [Related]
14. Current tobacco control policy trends in the United States.
Stoner WI; Foley BX
Clin Occup Environ Med; 2006; 5(1):85-99, ix. PubMed ID: 16446256
[TBL] [Abstract][Full Text] [Related]
15. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
Williamson RT; Rodd J
BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
[TBL] [Abstract][Full Text] [Related]
16. Current trends in international tobacco control.
Thompson F; Fagerström K
Clin Occup Environ Med; 2006; 5(1):101-16, ix. PubMed ID: 16446257
[TBL] [Abstract][Full Text] [Related]
17. The National Tobacco Control Program: focusing on policy to broaden impact.
Wisotzky M; Albuquerque M; Pechacek TF; Park BZ
Public Health Rep; 2004; 119(3):303-10. PubMed ID: 15158109
[TBL] [Abstract][Full Text] [Related]
18. Has global fund support for civil society advocacy in the former Soviet Union established meaningful engagement or 'a lot of jabber about nothing'?
Harmer A; Spicer N; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
Health Policy Plan; 2013 May; 28(3):299-308. PubMed ID: 22767433
[TBL] [Abstract][Full Text] [Related]
19. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
Hall W; Gartner C
Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
[TBL] [Abstract][Full Text] [Related]
20. Applying an equity lens to tobacco-control policies and their uptake in six Western-European countries.
Giskes K; Kunst AE; Ariza C; Benach J; Borrell C; Helmert U; Judge K; Lahelma E; Moussa K; Ostergren PO; Patja K; Platt S; Prättälä R; Willemsen MC; Mackenbach JP
J Public Health Policy; 2007 Jul; 28(2):261-80. PubMed ID: 17585326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]